Promising advances in the treatment of malignant pancreatic endocrine tumors

N Engl J Med. 2011 Feb 10;364(6):564-5. doi: 10.1056/NEJMe1013903.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Disease Progression
  • Everolimus
  • Humans
  • Indoles / therapeutic use*
  • Neuroendocrine Tumors / drug therapy*
  • Pancreatic Neoplasms / drug therapy*
  • Protein Kinase Inhibitors / therapeutic use*
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Pyrroles / therapeutic use*
  • Quality of Life
  • Sirolimus / analogs & derivatives*
  • Sirolimus / therapeutic use
  • Sunitinib
  • TOR Serine-Threonine Kinases / antagonists & inhibitors

Substances

  • Antineoplastic Agents
  • Indoles
  • Protein Kinase Inhibitors
  • Pyrroles
  • Everolimus
  • MTOR protein, human
  • Protein-Tyrosine Kinases
  • TOR Serine-Threonine Kinases
  • Sunitinib
  • Sirolimus